Ares Capital Corporation (ARCC) - 2017 Annual Report Summary
Business Context and Reporting Period
Company: Ares Capital Corporation (ARCC)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2017
Business Model: Ares Capital is a closed-end, non-diversified management investment company regulated as a Business Development Company (BDC). It is externally managed by Ares Capital Management LLC, a subsidiary of Ares Management L.P. The company's objective is to generate current income and capital appreciation primarily through first and second lien senior secured loans, mezzanine debt, and equity investments in U.S. middle-market companies.
Key Financial Metrics
| Metric | 2017 | 2016 |
|---|---|---|
| Total Investment Income | $1,160 million | $1,012 million |
| Net Investment Income | $511 million | $494 million |
| Net Increase in Stockholders' Equity (Operations) | $667 million | $474 million |
| Net Asset Value (NAV) per Share | $16.65 | $16.45 |
| Total Assets | $12,347 million | $9,245 million |
| Total Debt (Principal Amount) | $4,943 million | $3,951 million |
| Weighted Average Yield (Total Portfolio) | 8.7% | 8.3% |
| Asset Coverage Ratio | 242% | 242% |
Material Changes vs. Prior Period
- Portfolio Growth: Total assets increased by approximately $3.1 billion (33.5%) to $12.3 billion, driven primarily by the acquisition of American Capital, Ltd. in January 2017, which added $3.6 billion in assets.
- Investment Activity: New investment commitments totaled $5.9 billion in 2017 compared to $3.7 billion in 2016. The company funded $5.7 billion in investments during the year.
- Expense Increase: Total expenses (net of fee waivers) rose to $630 million from $497 million. This increase was due to higher base management fees (reflecting the larger asset base), higher interest expense, and $45 million in professional fees related to the American Capital Acquisition.
- Fee Waiver: In connection with the American Capital Acquisition, the investment adviser waived $30 million of income-based fees in 2017.
- Realized Gains: Net realized gains on investments were $44 million in 2017, compared to $110 million in 2016. This included a $140 million realized loss on the Infilaw Holding, LLC investment.
Guidance, Outlook, and Risks
Management Commentary: Management highlighted the successful integration of the American Capital portfolio and the company's position as the largest BDC in the U.S. The weighted average yield of the portfolio decreased slightly to 8.7% due to the inclusion of lower-yielding assets from the acquisition and the termination of the Senior Secured Loan Program (SSLP). The company maintains a disciplined investment philosophy focused on capital preservation and risk-adjusted returns.
Outlook: The company intends to continue borrowing under its credit facilities and may issue additional debt or equity to fund growth. It maintains a $300 million stock repurchase program (extended to February 2019) and expects to continue making quarterly distributions to maintain its Regulated Investment Company (RIC) status.
Risks and Contingencies:
- Legal Proceedings: The company is a defendant in a lawsuit filed by the bankruptcy trustee of DSI Renal Holdings LLC, seeking approximately $117 million in damages. The company believes the claims are without merit. Additionally, shareholder litigation regarding the American Capital Acquisition was settled in principle pending court approval.
- Interest Rate Risk: Approximately 81% of the portfolio bears variable interest rates. A 100 basis point increase in rates is estimated to increase net income by $89 million annually.
- Liquidity and Leverage: The company relies on debt financing and must maintain an asset coverage ratio of at least 200%. As of year-end, the ratio was 242%.
Key Facts for Investor Verification
- Acquisition Integration: Verify the progress of integrating the $2.5 billion investment portfolio acquired from American Capital and the realization of anticipated cost synergies.
- Non-Accrual Status: Monitor the 3.1% of total investments on non-accrual status (up from 2.9% in 2016) and the specific performance of the Infilaw Holding, LLC investment which generated a significant realized loss.
- Debt Maturities: Review the debt maturity schedule, noting $1.046 billion in principal payments due within one year (including $270 million in convertible notes and $750 million in senior notes).
- Fee Structure: Confirm the impact of the $30 million fee waiver on net investment income and the sustainability of the 1.5% base management fee and income-based fee structure.
- Legal Exposure: Track the status of the DSI Renal Holdings litigation and the final court approval of the American Capital shareholder settlement.